A recent Sacramento Bee story highlighted UC Davis progress on a new drug for chronic pain that, if successful in human trials, might help replace the addictive medications at the center of the country's opioid epidemic.
The novel medication being developed by Bruce Hammock, an entomologist with an appointment at the National Cancer Institute-designated UC Davis Comprehensive Cancer Center, has been reported both effective and non-addictive so far in animal trials.
Hammock, a member of the National Academy of Inventors, expects the new drug to enter human trials this fall. So far related clinical studies have received more than $4 million in federal support, as well as a $5 million commitment from the nonprofit Open Philanthropy Project.
Collaboration between human and animal health scientists is a unique hallmark of research at UC Davis, home to a related One Health Institute.
'The answer to opioid crisis? UC Davis researcher will soon test his non-addictive pain drug'
Sacramento Bee, April 29, 2019